Clinical Trial Update: Biomarkers of Phage Treatment Response in NTM and Other Infections

View source ↗

Summary

Clinical trial investigating biomarkers of phage treatment response in nontuberculous mycobacterial lung disease, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nontuberculous Mycobacterial Lung Disease

Drugs mentioned

• Bacteriophage therapy

Snippet

Sponsor: NYU Langone Health | Conditions: Nontuberculous Mycobacterial Lung Disease | Status: RECRUITING